col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


41 Ergebisse       Seite 1

 [1] 
Wiley: ChemBioChem
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Feb―21 Biomimetic Recognition of SARS-CoV-2 Receptor-Binding Domain N-Glycans by an Antiviral Synthetic Receptor. Carlo Santambrogio, Mirco Toccafondi, Lorena Donnici, Elisa Pesce, Raffaele De Francesco, Renata Grifantini, et al. (+7)
2 [GO] 2024―Dez―23 Cover Feature: Targeting SARS-CoV-2 Proteins: In Silico Investigation with Polypyridyl-Based Zn(II)-Curcumin Complexes (ChemBioChem 24/2024) Vedant Gawande, Rajesh Kushwaha, Arif Ali Mandal, Samya Banerjee
3 [GO] 2024―Okt―31 Distinct Effects of SARS-CoV-2 Protein Segments on Structural Stability, Amyloidogenic Potential, and α-Synuclein Aggregation Vince St. Dollente Mesias, Jianing Zhang, Hongni Zhu, Xin Dai, Jixi Li, Jinqing Huang
4 [GO] 2024―Okt―17 Design and evaluation of peptide inhibitors targeting the dimerization of SARS-CoV-2 main protease Lu Liu, Yi Yang, Zhiyi Zhao, Xiaoying Li, Yian Chen, Shao-Lin Zhang, Aimin Yang
5 [GO] 2024―Sep―12 Targeting SARS-CoV-2 proteins: In Silico Investigation with Polypyridyl-based Zn(II)-Curcumin Complexes Vedant Gawande, Rajesh Kushwaha, Arif Ali Mandal, Samya Banerjee
6 [GO] 2024―Jun―15 Super-resolution imaging reveals the mechanism of endosomal acidification inhibitors against SARS-CoV-2 infection Chunyu Yan, Wei Zhou, Yan Zhang, Xuelian Zhou, Qinglong Qiao, Lu Miao, Zhaochao Xu
7 [GO] 2024―Mai―09 Allosteric Regulation and Inhibition of Coronavirus 3CLpro Revealed by HDX-MS Ning Song, Wen Zheng, Bin Song, Jie Zheng
8 [GO] 2024―Mai―06 Amplification- and Enzyme-Free Magnetic Diagnostics Circuit for Whole-Genome Detection of SARS-CoV-2 RNA Enja Laureen Rösch, Rebecca Sack, Mohammad Suman Chowdhury, Florian Wolgast, Margarete Zaborski, Frank Ludwig, et al. (+4)
9 [GO] 2024―Apr―13 SARS-CoV-2 Spike Protein-Derived Cyclic Peptides as Modulators of Spike Interaction with GRP78 Nicholas Johnson, Craig Pattinson, Kate Burgoyne, Karolin Hijazi, Wael E Houssen, Bruce Forbes Milne
10 [GO] 2023―Aug―14 Conventional understanding of SARS-CoV-2 Mpro and common strategies for developing its inhibitors Kun Zhou, Daquan Chen
11 [GO] 2023―Jun―21 Reflections on Navigating a Pandemic: Perspectives from the Chemical Biology Community Anne C. Conibear, Nina Hartrampf
12 [GO] 2023―Apr―18 Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors Patrick Moon, Charlotte Zammit, Qian Shao, Lydia Boike, Dustin Dovala, Nathaniel J Henning, et al. (+17)
13 [GO] 2023―Apr―06 Epitopes displayed in a cyclic peptide scaffold bind SARS-CoV-2 antibodies Camilla Eriksson, Sunithi Gunasekera, Taj Muhammad, Mingshu Zhang, Ida Laurén, Sara M Mangsbo, et al. (+2)
14 [GO] 2023―Feb―08 Effects of Epitranscriptomic RNA Modifications on the Catalytic Activity of SARS-CoV-2 Replication Complex Alexander Apostle, Yipeng Yin, Komal Chillar, Adikari M. D. N. Eriyagama, Reed Arneson, Emma Burke, et al. (+2)
15 [GO] 2022―Nov―24 Pineapple Lectin AcmJRL binds SARS-CoV-2 Spike Protein in a carbohydrate-dependent fashion Joscha Meiers, Jan Dastbaz, Sebastian Adam, Sari Rasheed, Susanne H. Kirsch, Peter Meiser, et al. (+3)
16 [GO] 2022―Okt―20 Identification of Potential Antiviral Disaccharide Leading Compounds against SARS-CoV-2 through A Computer Aided Study Binjie Li, Tianji Zhang, Jin-ping Li, Ming-jia Yu
17 [GO] 2022―Aug―22 SARS-CoV-2 Papain-Like Protease: Structure, Function and Inhibition Sven Ullrich, Christoph Nitsche
18 [GO] 2022―Aug―16 NMR Observation of Sulfhydryl Signals in SARS-CoV-2 Main Protease Aids Structural Studies Angus J. Robertson, Jinfa Ying, Ad Bax
19 [GO] 2022―Jul―06 Corrigendum: Hidden in Plain Sight: Natural Products of Commensal Microbiota as an Environmental Selection Pressure for the Rise of New Variants of SARS-CoV-2 Jovan Dragelj, Maria Andrea Mroginski, Kourosh H. Ebrahimi
20 [GO] 2022―Jul―04 Synthetic α-Helical Peptides as Potential Inhibitors of the ACE2 SARS-CoV-2 Interaction Pascal M. Engelhardt, Sebastián Florez Rueda, Marco Drexelius, Jörg-Martin Neudörfl, Daniel Lauster, Christian P. R. Hackenberger, et al. (+3)
21 [GO] 2022―Jun―02 Luminescent Assay for the Screening of SARS-CoV-2 MPro Inhibitors Daan Sondag, Jona Merx, Emiel Rossing, Thomas J. Boltje, Dennis W. P. M. Löwik, Frank H. T. Nelissen, et al. (+4)
22 [GO] 2022―Mai―31 Why Omicron Variant of SARS-CoV-2 is Less Fatal? Lipeng Liao, Jiaming Zhang, Yuchuan Wang, Qiuyun Liu
23 [GO] 2022―Apr―01 Omicron: Understanding the latest variant of SARS-CoV-2 and strategies for tackling the infection SREEKANTH REDDY OBIREDDY, Ujwala Guntakanti, Anitha Kowthalam, Subha Marata Chinna Subbarao, Wing-Fu Lai
24 [GO] 2021―Nov―05 The Role of Spike Protein Mutations in the Infectious Power of SARS-COV-2 Variants: A Molecular Interaction Perspective Santiago A. Gómez, Natalia Rojas-Valencia, Sara Gómez, Chiara Cappelli, Albeiro Restrepo
25 [GO] 2021―Sep―20 On the weak binding and spectroscopic signature of SARS-CoV-2 nsp14 interaction with RNA Ayaz Hassan, Graziela C Sedenho, Phelipe A. M. Vitale, Mona N Oliveira, Frank Nelson Crespilho
26 [GO] 2021―Sep―16 The role of spike protein mutations in the infectious power of SARS-COV-2 variants: A molecular interaction perspective Santiago A Gomez, Natalia Rojas-Valencia, Sara Gomez, Chiara Cappelli, Albeiro Restrepo
27 [GO] 2021―Jul―15 Hidden in plain sight: Natural products of commensal microbiota as an environmental selection pressure for the rise of new variants of SARS-CoV-2 Jovan Draglj, Maria Andrea Mroginski, Kourosh Honarmand Ebrahimi
28 [GO] 2021―Jun―23 Preliminary Structural Data Revealed that the SARS-CoV-2 B.1.617 Variant’s RBD binds to ACE2 receptor stronger than the Wild Type to Enhance the Infectivity Abbas Khan, Dong-Qing Wei, Kafila Kousar, Jehad Abubaker, Sajjad Ahmad, Javaid Ali, et al. (+5)
29 [GO] 2021―Jun―16 α V β 6 Integrin: An Intriguing Target for COVID-19 and Related Diseases Kelly Bugatti
30 [GO] 2021―Mai―18 Metal Complexes as Antiviral Agents for SARS-CoV-2 Johannes Karges, Seth M. Cohen
31 [GO] 2020―Dez―22 Ferritin as a Platform for Creating Antiviral Mosaic Nanocages: Prospects for Treating COVID-19 Kourosh Honarmand Ebrahimi
32 [GO] 2020―Nov―13 Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2 Merel A. T. Plassche, Marta Barniol-Xicota, Steven H. L. Verhelst
33 [GO] 2020―Nov―11 Computational Hot-Spot Analysis of the SARS-CoV-2 Receptor Binding Domain / ACE2 Complex Brian McNaughton, Pedro A. Rosario
34 [GO] 2020―Okt―29 Optical Biosensors for Virus Detection: Prospects for COVID-19 Hemanth Maddali, Catherine E Miles, Joachim Kohn, Deirdre Marie O'Carroll
35 [GO] 2020―Okt―21 Why does the novel Coronavirus Spike Protein interact so strongly with the human ACE2? A thermodynamic answer. Jones de Andrade, Paulo Fernando Bruno Gonçalves, Paulo Augusto Netz
36 [GO] 2020―Okt―08 Tackling SARS-CoV-2 Infections using Remdesivir and Favipiravir as Therapeutic Options SREEKANTH REDDY OBIREDDY, Lai Wing-Fu
37 [GO] 2020―Sep―28 Binding of SARS-CoV-2 to cell receptors: a tale of molecular evolution Santiago A. Gomez, Natalia Rojas-Valencia, Sara Gomez, Franco Egidi, Chiara Cappelli, Albeiro Restrepo
38 [GO] 2020―Sep―22 Chemical Translational Biology-Guided Molecular Diagnostics: The Front Line To Mediate the Current SARS-CoV-2 Pandemic Yifan Dai
39 [GO] 2020―Jul―27 Peptidyl Acyloxymethyl Ketones as Activity-Based Probes for the Main Protease of SARS-CoV-2 Merel A. T. van de Plassche, Marta Barniol-Xicota, Steven Verhelst
40 [GO] 2020―Mai―05 Trends and innovations in biosensors for COVID-19 mass testing Ibon Santiago
41 [GO] 2020―Feb―05 Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV Wenshe Liu, Jared S. Morse, Tyler Lalonde, Shiqing Xu
 [1] 

41 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec